The first experience of therapeutic dendritic cells vaccine administration in patients with extensively drug resistant lung tuberculosis

A. Starshinova (St.-Peterburg, Russian Federation), M. Filatov (St.-Peterburg, Russian Federation), M. Nazarenko (St.-Peterburg, Russian Federation), V. Burdakov (St.-Peterburg, Russian Federation), S. Landa (St.-Peterburg, Russian Federation), E. Istomina (St.-Peterburg, Russian Federation), G. Marfina (St.-Peterburg, Russian Federation), P. Yablonskiy (St.-Peterburg, Russian Federation)

Source: International Congress 2018 – Drug-resistant tuberculosis
Session: Drug-resistant tuberculosis
Session type: Poster Discussion
Number: 3682
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Starshinova (St.-Peterburg, Russian Federation), M. Filatov (St.-Peterburg, Russian Federation), M. Nazarenko (St.-Peterburg, Russian Federation), V. Burdakov (St.-Peterburg, Russian Federation), S. Landa (St.-Peterburg, Russian Federation), E. Istomina (St.-Peterburg, Russian Federation), G. Marfina (St.-Peterburg, Russian Federation), P. Yablonskiy (St.-Peterburg, Russian Federation). The first experience of therapeutic dendritic cells vaccine administration in patients with extensively drug resistant lung tuberculosis. 3682

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: